A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults

Clinical trial NCT04816669 · COMPLETED

Trial details

NCT number: NCT04816669
Sponsor: BioNTech SE
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

SARS-CoV-2 Infection COVID-19

Start date: 2021-04-01
Primary completion: 2021-12-01
Enrollment: 629

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.